Live Attenuated Influenza A Virus Vaccine
DBCAT004003Therapeutic category
A DrugBank category of 8 drugs. 8 of them are approved.
- Part of
- Influenza Vaccines
- Drugs
- Influenza A virus A/California/7/2009 (H1N1) live (attenuated) antigen
- Influenza A virus A/Norway/16606/2021 (H3N2) live (attenuated) antigen
- Influenza A virus A/Norway/31694/2022 (H1N1) live (attenuated) antigen
- Influenza A virus A/Perth/16/2009 (H3N2) live (attenuated) antigen
- Influenza A virus A/Perth/722/2024 (H3N2) live (attenuated) antigen
- Influenza A virus A/Tasmania/503/2020 (H3N2) live (attenuated) antigen
- Influenza A Virus A/Thailand/8/2022 IVR-237 (H3N2) whole
- Influenza A virus A/Victoria/1/2020 (H1N1) live (attenuated) antigen
What you can answer from here — as of September 15, 2022
Which Live Attenuated Influenza A Virus Vaccine are approved where, and how do their indications and safety profiles compare?
Create a free account or log in to explore the full data card.
Create Account